478
edits
No edit summary |
No edit summary |
||
Line 3: | Line 3: | ||
<!-- [[Category:Lab]] --> | <!-- [[Category:Lab]] --> | ||
<font size="2"> | <font size="2"> | ||
Dr. David J. Klinke II is an Associate Professor in the [http:// | Dr. David J. Klinke II is an Associate Professor in the [http://cbe.statler.wvu.edu Department of Chemical and Biomedical Engineering] in the Benjamin M. Statler College of Engineering and Mineral Resources (CEMR) at WVU. In addition to his position in Chemical Engineering, he is a Member of the Mary Babb Randolph Cancer Center and an Adjunct Associate Professor of [http://www.hsc.wvu.edu/som/micro Microbiology, Immunology, and Cell Biology] in the WVU School of Medicine. He received his Ph.D. in Chemical Engineering from [http://www.northwestern.edu Northwestern University] in 1998, where his research focus was on developing rule-based models of complicated chemical reaction networks. From 1999 until joining WVU in 2006, he developed large-scale mathematical models of immunologic and metabolic diseases for one of the commercial pioneers in the [http://www.nigms.nih.gov/News/Reports/201110-syspharma.htm emerging field of systems pharmacology]: [http://www.entelos.com Entelos, Inc.] His current research integrates ideas drawn from probability, statistics, high performance computing, and chemical kinetics with high-content experimental assays and proteomic methods to address outstanding problems in cancer immunology and cellular signal transduction. A visual representation of the recent publications from the lab are shown below. | ||
[[Image:Wordle-081314.tif|700px|center]] | [[Image:Wordle-081314.tif|700px|center]] |
edits